Opening Remarks

Saturday, March 8, 2025

8:00 AM – 8:05 AM ET

Speaker(s)

Farooq Sheikh, MD

Medical Director, Advanced Heart Failure Program
MedStar Health, Georgetown University School of Medicine
Washington, District of Columbia, United States

Disclosure(s): Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Alnylam: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); AstraZeneca Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); bridgebio: Consulting Fees (e.g., advisory boards) (Ongoing); Intellia: Grant/Research Support (Ongoing); Pfizer,: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); procyrion: Consulting Fees (e.g., advisory boards) (Ongoing); XVIVO: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):

Farooq Sheikh, MD: Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Alnylam: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); AstraZeneca Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); bridgebio: Consulting Fees (e.g., advisory boards) (Ongoing); Intellia: Grant/Research Support (Ongoing); Pfizer,: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); procyrion: Consulting Fees (e.g., advisory boards) (Ongoing); XVIVO: Consulting Fees (e.g., advisory boards) (Ongoing)